BRUSSELS (Reuters) – Belgian biotech company Ablynx has signed a deal with Merck & Co worth up to 1.7 billion euros ($2.3 billion) to develop ways of triggering the body to fight cancer by itself.
The collaboration involves a new generation of drugs designed to activate the immune system. The first in the field – Bristol-Meyer Squibb’s Yervoy – is targeting melanoma, the deadliest form of skin cancer.
UTRECHT, Netherlands/BRUSSELS (Reuters) – U.S. cable group Liberty Global (LBTYA.O: Quote, Profile, Research) has won its 10-month pursuit of Ziggo (ZIGGO.AS: Quote, Profile, Research) with a deal that values the Dutch operator and its debt at 10 billion euros ($13.7 billion) and expands billionaire John Malone’s vast European cable empire.
Ziggo rejected an initial offer from Liberty last October as too low, seven months after the U.S. group controlled by Malone first bought shares in its Dutch target.
BRUSSELS (Reuters) – U.S. cable group Liberty Global has agreed to buy Ziggo in a cash and share deal valuing the Dutch operator at 10 billion euros ($13.7 billion) to expand its reach across Europe.
Ziggo, which in October rejected an earlier offer from Liberty as too low, said in a joint statement on Monday that the current offer implied a price of 34.53 euros per share compared with Friday’s close of 33.25 euros.
BRUSSELS (Reuters) – The U.S. Federal Reserve will take center stage in the week ahead with a widely expected cut to its bond-buying stimulus, responding to an improving U.S. economy but also helping fuel a dramatic emerging market sell-off.
Argentina, Turkey and Ukraine felt the full force last week of a global flight from developing world assets as investors grew concerned about slower growth in China and U.S. monetary tightening, as well as the countries’ own problems.
BRUSSELS, Jan 24 (Reuters) – Dutch cable group Ziggo NV
, which is in talks on a takeover by U.S. peer Liberty
Global Plc, forecast unchanged core earnings for 2014
with investments in promotions and in its new mobile service
offsetting revenue growth.
The group said there was little it could say about its talks
with Liberty, which it revealed in December. It had previously
rejected an offer as too low.
BRUSSELS, Jan 23 (Reuters) – Belgian supermarket group
Delhaize reported broadly unchanged fourth-quarter
revenue on Thursday as sales growth in both the United States
and Belgium were neutralised by a weaker dollar.
The group, which has about 3,500 stores worldwide and makes
about 60 percent of its revenue in the United States, said
revenue inched up by 0.1 percent, or 3.0 percent at identical
exchange rates, to 5.34 billion euros ($7.24 billion).
HONG KONG/BRUSSELS (Reuters) – Anheuser-Busch InBev SA, the world’s biggest brewer, agreed to buy back South Korea’s Oriental Brewery Co Ltd (OB) for $5.8 billion including debt, returning to a large Asian market at a time of strong industry growth across the region.
The sale by KKR & Co and Affinity Equity Partners will be Asia’s biggest ever for private equity, excluding flotations, and rewards them with returns of more than five times their investment.
BRUSSELS (Reuters) – Belgian mobile telephone operator Mobistar set cable operators a six-month deadline on Friday to open up their networks, allowing it to start its own television and fixed-line phone and internet services by the end of the year.
Mobistar said in a statement it had paid 600,000 euros ($816,100) to Telenet, which is active in the northern region of Flanders, and the same amount to southern Belgian cable operator Brutele-Tecteo.
BRUSSELS (Reuters) – Dutch grocer Ahold (AHLN.AS: Quote, Profile, Research, Stock Buzz) reported a steeper-than-expected decline in fourth-quarter sales, as the U.S. food market contracted and customers in the Netherlands spent less per visit to its shops.
The group, which makes three-fifths of its revenue in the United States, said on Thursday sales fell by 4.2 percent, or 1.1 percent at constant exchange rates, to 7.47 billion euros ($10.2 billion).
BRUSSELS (Reuters) – Belgian medical researchers have succeeded in repairing bones using stem cells from fatty tissue, with a new technique they believe could become a benchmark for treating a range of bone disorders.
The team at the Saint Luc university clinic hospital in Brussels have treated 11 patients, eight of them children, with fractures or bone defects that their bodies could not repair, and a spin-off is seeking investors to commercialize the discovery.